Registry Study on Biological Disease Profile and Clinical Outcome in Patients with Newly Diagnosed Breast or Ovarian Cancer The BRandO Biology and Outcome (BiO)-Project

Registry Study on Biological Disease Profile and Clinical Outcome in Patients with Newly Diagnosed Breast or Ovarian Cancer The BRandO Biology and Outcome (BiO)-Project - BRandO BiO

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00009989

Enrollment

4000

Registered

2016-02-04

Start date

2016-01-18

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50 C56

Interventions

Group 1: 1. register all patients with newly diagnosed breast or ovarian cancer in all BRandO-BiO participating centers 2. assess and verify tumor classification and other data according to the requir

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with primary newly diagnosed of breast or ovarian cancer Age = 18 years. There is no upper age limit. signed informed consent

Exclusion criteria

Exclusion criteria: Severe neurological or psychiatric disorder interfering with ability to give an informed consent No consent for registration, storage and processing of the individual disease characteristics and course

Design outcomes

Primary

Measure	Time frame
Objectives: - Incidence of different molecular aberrations - To document treatment decisions (intensive, non-intensive, investigational) - Progression-free survival (PFS) - Overall survival (OS)	—

Secondary

Measure	Time frame
end of study 30.04.2023	—

Countries

Germany

Contacts

Public ContactJens Huober

Universitätsklinikum Ulm, Klinik für Frauenheilkunde und Geburtshilfe

Jens.Huober@uniklinik-ulm.de0731/500-58511

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026